U.S. FDA approves COVID-19 booster for those aged 12 to 15

The U.S. Food and Drug Administration has authorized the use of a third dose of the Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15 years.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting